There is no notable decline in sensitivity from intermediate- to high-grade cases, albeit the overall sensitivity is less than TTF-1 and napsin A. Surfactant protein-A and -B share a comparable sensitivity with MAdL in intermediate-grade cases, whereas their expression ceased notably in high-grade carcinomas (Figure 2B). Here, NAPSA is linked to carcinoma.